Clinical trial
Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
NCT00001728 · National Institute of Dental and Craniofacial Research (NIDCR), NIH · Completed
Key facts
| NCT number | NCT00001728 |
|---|---|
| Title | Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome |
| Official title | A Randomized, Placebo-Controlled Trial of Alendronate in the Treatment of Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome |
| Lead sponsor | National Institute of Dental and Craniofacial Research (NIDCR), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Polyostotic Fibrous Dysplasia |
| Intervention type | Drug |
| Interventions | Fosamax (Alendronate) |
| Enrollment | 40 |
| Start date | Aug 24, 1998 |
| Primary completion | Aug 19, 2007 |
| Completion | May 2, 2011 |
| First posted | Nov 4, 1999 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: